Minimally invasive spine surgery shown effective

Minimally invasive surgery can help patients suffering from worn and painful spinal disc degeneration in the same amount of time as standard, more invasive procedures, a study shows. (Oct. 29, 2008)

Still deadly after all these years

Researchers at Weill Cornell Medical College have located a gene that could mutate to make Y. pestis, the bacterium responsible for the Black Plague, resistant to many common drugs. (Oct. 29, 2008)

Wilson presents oral history of the Payne Whitney Clinic

In honor of the Payne Whitney Clinic's 75th anniversary, psychiatrist Peter Wilson compiled an oral history including more than 70 hours of audio tape and more than 58 individual video interviews. (Oct. 29, 2008)

New technique may ease pain and discomfort following prostate cancer surgery

To ease the pain of recovery following prostate cancer surgery, researchers have developed an innovative and patient-friendly approach that eliminates the use of a catheter. (Oct. 29, 2008)

New grant to support grad students in obesity prevention

A new grant from the U.S. Department of Agriculture will support three nutrition graduate students to focus on obesity, taking an ecological perspective. (Oct. 22, 2008)

Michael Latham honored with public lecture in Malaysia

Michael Latham, M.D., professor emeritus and graduate school professor of nutritional sciences at Cornell, was honored Oct. 7 with the Michael Latham Public Lecture in Penang, Malaysia. (Oct. 13, 2008)

For researchers in Weill Hall, collaboration between Ithaca and New York City is central

Weill Hall is designed for big-picture scientists: researchers who think beyond the confines of their field to tackle challenges in creative new ways. (Oct. 10, 2008)

New Cornell drink with protein punch debuts at New York Farm Day in D.C.

Cornell researcher David Barbano has developed new technology to isolate protein and calcium from skim milk to fortify all kinds of drinks with more nutrients. (Sept. 26, 2008)

Researchers discover how antidepressants and cocaine interact with their protein targets in brain cells

Researchers describe how brain cells process antidepressants, cocaine and amphetamines. The findings could lead to more targeted medications for psychiatric diseases and addiction. (Sept. 17, 2008)